$2.37
-0.05-2.07%
Pre-Market: 4:26 AM EDT
15 minutes delayed
Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
VVOS | Vivos Therapeutics | -$0.18 | -$1.05 | — | — | $3.40M | $3.60M | — | — | 08/12/2024 | Get Alert |
VVOS | Vivos Therapeutics | -$1.72 | — | -$1.63 | — | $3.86M | — | $3.42M | — | 05/14/2024 | Get Alert |
VVOS | Vivos Therapeutics | -$5.00 | -$1.90 | -$3.05 | -60.53% | $3.95M | $3.41M | $3.25M | -4.75% | 03/28/2024 | Get Alert |
VVOS | Vivos Therapeutics | -$6.50 | — | -$1.75 | — | $4.25M | — | $3.30M | — | 11/14/2023 | Get Alert |
VVOS | Vivos Therapeutics | -$8.25 | -$3.50 | -$4.50 | -28.57% | $4.18M | $4.15M | $3.40M | -18.19% | 08/16/2023 | Get Alert |
VVOS | Vivos Therapeutics | -$6.50 | -$4.50 | -$5.00 | -11.11% | $3.46M | $4.01M | $3.86M | -3.82% | 06/08/2023 | Get Alert |
VVOS | Vivos Therapeutics | -$8.50 | -$5.50 | -$5.00 | 9.09% | $4.39M | $4.55M | $3.95M | -13.19% | 03/30/2023 | Get Alert |
VVOS | Vivos Therapeutics | -$4.75 | — | -$8.25 | — | $4.50M | $3.81M | $4.18M | 9.82% | 12/20/2022 | Get Alert |
VVOS | Vivos Therapeutics | -$6.50 | — | -$6.50 | — | $4.55M | $3.72M | $4.25M | 14.14% | 12/20/2022 | Get Alert |
VVOS | Vivos Therapeutics | -$4.75 | -$6.50 | -$6.50 | 0.00% | $3.45M | $4.44M | $3.46M | -22.07% | 05/16/2022 | Get Alert |
VVOS | Vivos Therapeutics | -$12.00 | — | -$8.50 | — | $3.30M | — | $4.39M | — | 03/31/2022 | Get Alert |
VVOS | Vivos Therapeutics | -$4.25 | -$4.50 | -$6.50 | -44.44% | $3.29M | $4.50M | $4.55M | 1.02% | 11/15/2021 | Get Alert |
VVOS | Vivos Therapeutics | — | -$4.50 | -$4.75 | -5.56% | — | $3.60M | $4.50M | 24.92% | 08/12/2021 | Get Alert |
VVOS | Vivos Therapeutics | -$5.75 | — | -$4.75 | — | $3.20M | — | $3.45M | — | 05/17/2021 | Get Alert |
VVOS | Vivos Therapeutics | — | -$4.00 | -$12.00 | -200.00% | $3.10M | $3.21M | $3.30M | 2.80% | 03/25/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $-3.05 | $-1.90 | -60.5 % |
Jun 2023 | 2023-08-16 | $-4.50 | $-3.50 | -28.6 % |
Mar 2023 | 2023-06-08 | $-5.00 | $-4.50 | -11.1 % |
Dec 2022 | 2023-03-30 | $-5.00 | $-5.50 | 9.09 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $3.25M | $3.41M | -4.75 % |
Jun 2023 | 2023-08-16 | $3.40M | $4.15M | -18.2 % |
Mar 2023 | 2023-06-08 | $3.86M | $4.01M | -3.82 % |
Dec 2022 | 2023-03-30 | $3.95M | $4.55M | -13.2 % |
Vivos Therapeutics (VVOS) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-1.63, which missed the estimate of $0.00.
The Actual Revenue was $3.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.